Tert-Butylamine

Tert-Butylamine

SCHEMBL28093808

CC(C)(C)N.Cc1cncc(C(=O)NC(C)c2ccc(OCC(F)(F)F)nc2)n1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
IDH1 known ✓ O75874 1/20 0.40
EPHX2 P34913 3/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP2J2 P51589 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.39
PDE2A O00408 10/20 0.39
P2RX3 P56373 1/20 0.38
P2RX2 Q9UBL9 1/20 0.38
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28129477 0.96 EPHX2 (0.42) EPHX2CYP2C9CYP2C19CYP2J2IDH1
Tert-Butylamine SCHEMBL28129319 0.88 PDE2A (0.43) PDE2AHTTSMN1; SMN2
Tert-Butylamine SCHEMBL28129278 0.87 EPHX2 (0.40) EPHX2CYP2C9PDE2AP2RX3P2RX2
Tert-Butylamine SCHEMBL28093771 0.86 HTT (0.53) EPHX2CYP2C9CYP2C19CYP2J2IDH1
Tert-Butylamine SCHEMBL27931938 0.85 EPHX2 (0.42) EPHX2CYP2C9CYP2C19CYP2J2IDH1
Tert-Butylamine SCHEMBL28130129 0.84 P2RX3 (0.39) PDE2AP2RX3P2RX2
Tert-Butylamine SCHEMBL27913922 0.83 EPHX2 (0.43) EPHX2CYP2C9CYP2C19CYP2J2IDH1
Tert-Butylamine SCHEMBL28093735 0.83 ROCK2 (0.44) CYP2C9PDE2AP2RX3P2RX2MAPK1
Tert-Butylamine SCHEMBL27913627 0.82 EPHX2 (0.47) EPHX2CYP2C9CYP2C19CYP2J2IDH1
SCHEMBL28840721 0.82 HTT (0.56) EPHX2CYP2C9CYP2C19CYP2J2IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106478497-A Aryl amine derivatives as TTX S blocker 拉夸里亚创药株式会社 2017-03-08 CN claimed
CN-103249721-B Arylamine Derivatives as TTX-S Blockers 拉夸里亚创药株式会社 2016-10-12 CN claimed